Zomedica Corp. received a deficiency letter from NYSE American indicating non-compliance with listing standards, requiring a reverse stock split or sustained price improvement by March 12, 2024.
AI Assistant
ZOMEDICA CORP
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.